The importance of cost inputs and sensitivity analyses in a cost-effectiveness analysis.
Jenna L
JL
Yoder Pharmd
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000191:economics*; D003362:Cost-Benefit Analysis / Q000379:methods; D003663:Decision Trees; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000191:economics; D018803:Models, Economic